China bans imports of Illumina's gene sequencers amid tariff war
While in positive territory ahead of Tuesday's market close, Illumina (ILMN) shares have fallen to a 52-week low after Chinese officials banned imports of its genetic sequencing equipment following President Trump's latest tariffs. Yahoo Finance senior health reporter Anjalee Khemlani comes on Market Domination to speak more about the situation. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.